Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes

被引:11
作者
Hayashi, Y. [1 ]
Toshida, H. [1 ]
Matsuzaki, Y. [1 ]
Matsui, A. [1 ]
Ohta, T. [1 ]
机构
[1] Juntendo Univ, Shizuoka Hosp, Dept Ophthalmol, Shizuoka, Japan
关键词
rebamipide; diabetic keratitis; corneal epithelium; wound healing;
D O I
10.2147/IMCRJ.S103299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Rebamipide ophthalmic suspension was developed for the treatment of dry eyes and for other corneal diseases, promoting the secretion of both mucin in tear fluid and membrane-associated mucin, increasing the number of goblet cells, and restoring the barrier function of the corneal epithelium. We report a case of a persistent corneal epithelial defect in a patient with diabetes treated with topical application of rebamipide ophthalmic suspension. Case presentation: A 73-year-old woman had a history of type 2 diabetes for 35 years and nonproliferative diabetic retinopathy for 23 years. She presented to our department with discharge and ophthalmalgia in the left eye. A corneal ulcer was detected, and culture of corneal scrapings was performed, with Staphylococcus aureus and Streptococcus canis being isolated. The infection was treated with levofloxacin eye drops and ofloxacin ophthalmic ointment based on the sensitivity profile of the isolate. However, a corneal epithelial defect persisted for approximately 2 months despite continuing treatment with 0.1% hyaluronic acid ophthalmic suspension and 0.3% ofloxacin eye ointment. Her hemoglobin A1c was 7.3%. The persistent corneal epithelial defect showed improvement at 2 weeks after treatment with rebamipide unit dose 2% ophthalmic suspension, and it did not recur even when vitrectomy was subsequently performed for vitreous hemorrhage due to progression of diabetic retinopathy. Conclusion: This is the first report about efficacy of rebamipide unit dose 2% ophthalmic suspension for presenting persistent corneal epithelial defect in a patient with diabetes. In the present case, the suggested mechanisms are the following: improving the corneal barrier function, stabilization of mucin on the keratoconjunctival epithelium, and improving the wettability and stability of the tear film, which resulted in the promotion of healing of the corneal epithelial defect in a short time period.
引用
收藏
页码:113 / 116
页数:7
相关论文
共 33 条
[1]   Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sjogren's Syndrome [J].
Arakaki, Rieko ;
Eguchi, Hiroshi ;
Yamada, Akiko ;
Kudo, Yasusei ;
Iwasa, Akihiko ;
Enkhmaa, Tserennadmid ;
Hotta, Fumika ;
Mitamura-Aizawa, Sayaka ;
Mitamura, Yoshinori ;
Hayashi, Yoshio ;
Ishimaru, Naozumi .
PLOS ONE, 2014, 9 (05)
[2]   Effect of Rebamipide Ophthalmic Suspension on Signs and Symptoms of Keratoconjunctivitis Sicca in Sjogren Syndrome Patients With or Without Punctal Occlusions [J].
Arimoto, Atsushi ;
Kitagawa, Kazuko ;
Mita, Norihiro ;
Takahashi, Yoriko ;
Shibuya, Eri ;
Sasaki, Hiroshi .
CORNEA, 2014, 33 (08) :806-811
[3]  
DeMill DL, 2015, BR J OPHTHALMOL
[4]  
Itakura H, 2013, CLIN OPHTHALMOL, V7, P2137, DOI [10.2147/OPTH.S54511, 10.2147/OPTH.S5451]
[5]   Topical rebamipide improves the ocular surface in mild lagophthalmos [J].
Itakura, Mariko ;
Itakura, Hirotaka ;
Kashima, Tomoyuki ;
Akiyama, Hideo ;
Kishi, Shoji .
CLINICAL OPHTHALMOLOGY, 2013, 7 :1333-1338
[6]   Prevention of diabetic keratopathy [J].
Kaji, Y .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (03) :254-255
[7]   Therapeutic use of Focus® Night & Day™ contact lenses [J].
Kanpolat, A ;
Uçakhan, ÖÖ .
CORNEA, 2003, 22 (08) :726-734
[8]   Resolution of persistent corneal erosion after administration of topical rebamipide [J].
Kashima, Tomoyuki ;
Akiyama, Hideo ;
Miura, Fumihide ;
Kishi, Shoji .
CLINICAL OPHTHALMOLOGY, 2012, 6 :1403-1406
[9]   Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy [J].
Kim, Junghyun ;
Kim, Chan-Sik ;
Sohn, Eunjin ;
Jeong, Il-Ha ;
Kim, Hyojun ;
Kim, Jin Sook .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (04) :529-536
[10]   Protection of Human Corneal Epithelial Cells From TNF-α-Induced Disruption of Barrier Function by Rebamipide [J].
Kimura, Kazuhiro ;
Morita, Yukiko ;
Orita, Tomoko ;
Haruta, Junpei ;
Takeji, Yasuhiro ;
Sonoda, Koh-Hei .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (04) :2752-2760